Aveanna Healthcare Holdings Inc AVAH.OQ AVAH.O is expected to show a rise in quarterly revenue when it reports results on August 7 for the period ending June 30 2025
The Atlanta Georgia-based company is expected to report a 6.0% increase in revenue to $535.367 million from $504.96 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for Aveanna Healthcare Holdings Inc is for earnings of 3 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and 2 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is $5.75, about 33.6% above its last closing price of $3.82
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | 0.00 | 0.00 | 0.10 | Beat | 7,093 |
Dec. 31 2025 | 0.00 | 0.00 | 0.05 | Beat | 2,100 |
Sep. 30 2024 | -0.01 | -0.01 | 0.02 | Beat | 260 |
Jun. 30 2024 | -0.01 | -0.02 | 0.01 | Beat | 150 |
Mar. 31 2024 | -0.05 | -0.05 | -0.03 | Beat | 36.8 |
Dec. 31 2023 | -0.02 | -0.02 | -0.02 | Met | 15.8 |
Sep. 30 2023 | -0.03 | -0.03 | -0.03 | Met | -12.5 |
Jun. 30 2023 | -0.04 | -0.04 | -0.02 | Beat | 44.8 |
This summary was machine generated August 5 at 13:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)